Sep 2026
First-in-human phase I study of DT-9081, a selective EP4 receptor antagonist, in advanced solid tumors.
R. Galot, Z. Castel-Ajgal, N. Kotecki et al.
· Investigational new drugs · 0 citations
1 paper indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.